|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1600 AUD | +3.23% |
|
0.00% | -5.88% |
| 10/07 | Neurizon Therapeutics Receives US FDA Support to Lift Clinical Hold on ALS Trial | MT |
| 03/07 | Elanco Animal Health Enters Into Licensing Agreement With Neurizon for Monepantel | MT |
Analyst Reco.
Search
No results for this search
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition